Intratumoral Administration of Adenoviral Interleukin 7 Gene-Modified Dendritic Cells Augments Specific Antitumor Immunity and Achieves Tumor Eradication-Reference-Cited by-同舟云学术

Intratumoral Administration of Adenoviral Interleukin 7 Gene-Modified Dendritic Cells Augments Specific Antitumor Immunity and Achieves Tumor Eradication

Published:2000-01 Issue:1 Volume:11 Page:53-65
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Miller Patrice W.,Sharma Sherven,Stolina Marina,Butterfield Lisa H.,Luo Jie,Lin Ying,Dohadwala Mariam,Batra Raj K.,Wu Lily,Economou James S.,Dubinett Steven M.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/10430340050016157

Reference46 articles.

1. Bcl-2 Rescues T Lymphopoiesis in Interleukin-7 Receptor–Deficient Mice

2. Dendritic Cells Pulsed with CEA Peptide Induce CEA-Specific CTL with Restricted TCR Repertoire

3. Dendritic cells and the control of immunity

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer;Cell Reports Medicine;2024-04

2. Germline mechanisms of immunotherapy toxicities in the era of genome‐wide association studies;Immunological Reviews;2023-07-28

3. Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression;OncoImmunology;2022-07-12

4. Interleukin-7 Biology and Its Effects on Immune Cells: Mediator of Generation, Differentiation, Survival, and Homeostasis;Frontiers in Immunology;2021-12-02

5. Enhanced Antitumor Responses of Tumor Antigen-Specific TCR T Cells Genetically Engineered to Produce IL7 and CCL19;Molecular Cancer Therapeutics;2021-10-21